In this webinar you will learn how combining genomics and machine learning provides a highly accurate in vitro method for qualitative and quantitative skin sensitizing potency assessment, filling in data gaps in safety testing projects.
The webinar will last around 30 minutes, followed by a live Q&A. Even If you cannot attend the live event, still register to get access to the recording of this webinar.
- How to use GARD for qualitative and quantitative skin sensitizing potency assessment.
- How the GARD technology works and why it is highly accurate and human-relevant.
- How customers across industries use the results for potency ranking of candidate ingredients and early decision-making during product development.